Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Extracellular vesicles and PD-L1 suppress macrophages, inducing therapy resistance in TP53 -deficient B-cell malignancies

Blood (2022) 139 (25): 3617–3629.

https://doi.org/10.1182/blood.2021014007

Published: 2022

Includes: Supplemental data

Journal Articles

Novel Tyrosine Kinase Inhibitors Trigger Drug Sensitivity of Primary CLL Cells by Controlling Glucosylation of Ceramides

Janine Schwamb, MD, Valeska Feldhaus, M.Sc., Michael Baumann, MD, Michaela Patz, PhD, Susanne Brodesser, PhD, Reinhild Brinker, Julia Claasen, Christian P. Pallasch, MD, Michael Hallek, MD, Clemens-Martin Wendtner, MD, Lukas P. Frenzel, MD

Blood (2012) 120 (21): 3905.

https://doi.org/10.1182/blood.V120.21.3905.3905

Published: 2012

Journal Articles

B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides

Janine Schwamb, Valeska Feldhaus, Michael Baumann, Michaela Patz, Susanne Brodesser, Reinhild Brinker, Julia Claasen, Christian P. Pallasch, Michael Hallek, Clemens-Martin Wendtner, Lukas P. Frenzel

Blood (2012) 120 (19): 3978–3985.

https://doi.org/10.1182/blood-2012-05-431783

Published: 2012

Includes: Supplemental data

Journal Articles

B-Cell Receptor-Mediated Glucosylceramide Synthesis Protects Primary CLL Cells From Ceramide-Dependent Apoptosis

Janine Schwamb, MD, Valeska Feldhaus, Susanne Brodesser, PhD, Reinhild Brinker, Julia Claasen, Christian P. Pallasch, MD, Michael Hallek, MD, Clemens Martin Wendtner, MD, Lukas P. Frenzel, MD

Blood (2011) 118 (21): 1766.

https://doi.org/10.1182/blood.V118.21.1766.1766

Published: 2011

Journal Articles

Primed for Death: Hypoxia Sensitizes Primary CLL Cells towards Compounds Targeting Mitochondrial Integrity

Lukas P. Frenzel, MD, Malte Huelsemann, Julia Claasen, Reinhild Brinker, Sebastian Theurich, MD, Hans Jiro Becker, Michael S. von Bergwelt-Baildon, MD, PhD, Christian P. Pallasch, MD, Michael Hallek, MD, Clemens Wendtner, MD

Blood (2011) 118 (21): 1767.

https://doi.org/10.1182/blood.V118.21.1767.1767

Published: 2011

Journal Articles

Palmitoylation Controls Death Receptor Function in Chronic Lymphocytic Leukemia

Lukas P. Frenzel, MD, Valeska Feldhaus, Marion Rusch, Reinhild Brinker, Julia Claasen, Christian P. Pallasch, MD, Herbert Waldmann, PhD, Michael Hallek, MD, Christian Hedberg, PhD, Clemens-Martin Wendtner, MD

Blood (2011) 118 (21): 2829.

https://doi.org/10.1182/blood.V118.21.2829.2829

Published: 2011

Journal Articles

B Cell Receptor Stimulation of CLL Cells Leads to Upregulation of IRF4 Proteinexpression Influenced by SNP Expression,

Michaela Patz, PhD, Nina-Felizitas Linde, Lukas P. Frenzel, MD, Christian P. Pallasch, MD, Reinhild Brinker, Julia Claasen, Michael Hallek, MD, Clemens Wendtner, MD

Blood (2011) 118 (21): 3886.

https://doi.org/10.1182/blood.V118.21.3886.3886

Published: 2011

Journal Articles

Novel X-Linked Inhibitor of Apoptosis (XIAP) Inhibiting Compound as Sensitizer for TRAIL-Mediated Apoptosis In Chronic Lymphocytic Leukemia with Poor Prognosis

Lukas P. Frenzel, MD, Michaela Patz, PhD, Christian P. Pallasch, MD, Reinhild Brinker, Julia Claasen, Alexandra Schulz, Michael Hallek, MD, Hamid Kashkar, PhD, Clemens-Martin Wendtner, MD

Blood (2010) 116 (21): 1375.

https://doi.org/10.1182/blood.V116.21.1375.1375

Published: 2010

Journal Articles

Sustained NF-Kappa B Activity In Chronic Lymphocytic Leukemia Is Independent of Genetic and Epigenetic Modifications of the Tumor Suppressor Genes CYLD and A20

Lukas P. Frenzel, MD, Janine Schwamb, MD, Rainer Claus, MD, Julia Claasen, Reinhild Brinker, Christian P. Pallasch, MD, Christoph Plass, PhD, Clemens-Martin Wendtner, MD

Blood (2010) 116 (21): 3597.

https://doi.org/10.1182/blood.V116.21.3597.3597

Published: 2010

Journal Articles

Disruption of T Cell Suppression in Chronic Lymphocytic Leukemia by CD200 Blockade.

Christian P Pallasch, MD, Susanne Ulbrich, MD, Reinhild Brinker, Robert A Uger, PhD, Michael Hallek, MD, Clemens- Martin Wendtner, MD

Blood (2008) 112 (11): 2072.

https://doi.org/10.1182/blood.V112.11.2072.2072

Published: 2008

NARROW

Extracellular vesicles and PD-L1 suppress macrophages, inducing therapy resistance in TP53 -deficient B-cell malignancies

Novel Tyrosine Kinase Inhibitors Trigger Drug Sensitivity of Primary CLL Cells by Controlling Glucosylation of Ceramides

B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides

B-Cell Receptor-Mediated Glucosylceramide Synthesis Protects Primary CLL Cells From Ceramide-Dependent Apoptosis

Primed for Death: Hypoxia Sensitizes Primary CLL Cells towards Compounds Targeting Mitochondrial Integrity

Palmitoylation Controls Death Receptor Function in Chronic Lymphocytic Leukemia

B Cell Receptor Stimulation of CLL Cells Leads to Upregulation of IRF4 Proteinexpression Influenced by SNP Expression,

Novel X-Linked Inhibitor of Apoptosis (XIAP) Inhibiting Compound as Sensitizer for TRAIL-Mediated Apoptosis In Chronic Lymphocytic Leukemia with Poor Prognosis

Sustained NF-Kappa B Activity In Chronic Lymphocytic Leukemia Is Independent of Genetic and Epigenetic Modifications of the Tumor Suppressor Genes CYLD and A20

Disruption of T Cell Suppression in Chronic Lymphocytic Leukemia by CD200 Blockade.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only